All 11 partners of the DESIREE project consortium had the chance to meet face to face, discuss the advances in their joint efforts, share views and opinions, consolidate the grounds of their collaboration, get involved in productive discussion and verify their upcoming goals and objectives as a team during the 1st Technical Meeting of the project that took place in Paris at the INSERM-LIMICS premises on September 29-30.
The meeting that was successfully organized by LIMICS was held right after the benchmark of the first 6 months of the project that kicked off on February 2016. The partners had thus the opportunity to both look back on what has already been achieved and set the more immediate and long term goals of DESIREE.
The 2nd day of the meeting, the team welcomed onboard the Project Advisory Board (PAB), a team of clinical experts from hospitals, research centers as well as patient associations all with a long experience in fighting breast cancer. PAB purpose is to provide guidance along the way, bridging DESIREE with the actual end users / clinical community needs.
DESIREE aims at developing a web-based software ecosystem for the personalized, collaborative and multidisciplinary management of primary breast cancer (PBC) by specialized BUs. Decision support will be provided on the available therapy options by incorporating experience from previous cases and bringing a holistic view of the patient presented to the BU through specialized visual exploratory interfaces.
In order to develop this system, a multidisciplinary consortium with complementary expertise has gathered around this idea. On one hand, the consortium includes technical experts in image analysis (Ulster University, Vicomtech-IK4, ARIVIS, ERESA), biology and genetics (Sistemas Genómicos, ERESA), predictive modelling (University of Houston, Medical Innovation and Technology, Sistemas Genómicos), decision support systems (Vicomtech-IK4, INSERM-LIMICS, Ulster University), visualization (ARIVIS, Vicomtech-IK4, Ulster University) and software development in the clinical domain (BILBOMATICA, ARIVIS).
On the other hand, it includes experts in all fields related to oncology, including end users with expertise in health technology assessment and validation for radiology (ERESA), decision support systems (Hôpital Tenon, Onkologikoa, ERESA) and breast surgery (University of Houston).
The DESIREE project has received funding from the European Union´s Horizon 2020 research and innovation programmme under grant agreement No 690238.
You can find out more about the project by browsing through its official website: http://www.desiree-project.eu/